Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Capecitabine, Oxaliplatin and Bevacizumab in Liver-only Metastatic Colorectal Cancer
NCT01022541Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jun 2006
- Primary completion
- Dec 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by Royal Marsden NHS Foundation Trust. Started Jun 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01022541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01022541.